Chemours

NYSE: CC · Real-Time Price · USD
15.07
0.42 (2.87%)
At close: Aug 14, 2025, 3:59 PM
15.24
1.09%
After-hours: Aug 14, 2025, 08:00 PM EDT

Chemours Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.78B 6.03B 6.79B 6.34B
Cost of Revenue
4.63B 4.72B 5.18B 4.96B
Gross Profit
1.15B 1.31B 1.62B 1.38B
Operating Income
458M -92M 913M 888M
Interest Income
n/a n/a n/a n/a
Pretax Income
127M -318M 741M 676M
Net Income
86M -238M 578M 608M
Selling & General & Admin
585M 1.29B 710M 592M
Research & Development
109M 108M 118M 107M
Other Expenses
14M n/a n/a n/a
Operating Expenses
708M 1.4B 828M 699M
Interest Expense
264M 208M 163M 185M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
5.33B 6.11B 6.01B 5.66B
Income Tax Expense
41M -81M 163M 68M
Shares Outstanding (Basic)
149.49M 148.91M 155.36M 164.94M
Shares Outstanding (Diluted)
150.01M 148.91M 158.3M 168.7M
EPS (Basic)
0.58 -1.6 3.72 3.69
EPS (Diluted)
0.57 -1.6 3.65 3.60
EBITDA
692M 197M 1.2B 1.21B
EBIT
391M -110M 793M 691M
Depreciation & Amortization
301M 307M 291M 317M